insights_auto
Nega BOT tushdi 10,00%?
Batafsil oʻrganishchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0090Â A$
arrow_downward
-10,00%(-0,0010) 1K
13-noy, 16:10:12 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01Â A$
Yuqori
0,01Â A$
Past
0,01Â A$
Bozor kapitali
24,86Â mln
Oʻrtacha hajm
10,14Â mln
Hajmi
947,25Â ming
52 haftalik eng yuqori
0,15Â A$
52 haftalik eng past
0,01Â A$
Aksiya boʻyicha daromad
-0,03Â A$
Muomaladagi aksiyalar
2,76Â mlrd
Xodimlar soni
11
Ochish
0,01Â A$
Yuqori
0,01Â A$
Past
0,01Â A$
Bozor kapitali
24,86Â mln
Oʻrtacha hajm
10,14Â mln
Hajmi
947,25Â ming
52 haftalik eng yuqori
0,15Â A$
52 haftalik eng past
0,01Â A$
Aksiya boʻyicha daromad
-0,03Â A$
Muomaladagi aksiyalar
2,76Â mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Trefis
·
4 soat oldin
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
qz.com
·
14 soat oldin
How much of the S&P 500 is Nvidia? Concentration explained
Reuters
·
21 soat oldin
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
Traders Union
·
21 soat oldin
S&P 500 falls over 1% as selling pressure and cautious trading weigh ahead of inflation data
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida